Barry George, MD
Cardiovascular Disease · Mount Vernon, OHNPI 1386605319
Payments from drug & device makers
What this record shows
This record is dominated by food and beverage: $4,554 of the $5,620 with a category attached, or 81.0%. 26 manufacturers reported payments, led by Abbott at 50.9% of the total. Reporting peaked in 2020 at $1,435 and has fallen 63.4% since, to $524 in 2025.
Across 210 payments — averaging $26.76 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Abbott$3K
- Endologix LLC$607
- Novartis$339
- Amgen$315
- ZOLL Services LLC (a/k/a ZOLL Lifecor Corp)$261
- Medtronic$187
- plus $1K from 20 others
What the payments were for
- Travel & lodging$1,05019%
- Food & beverage$4,55481%
- Education$170%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Abbott | 84 | $2,858 |
| Endologix LLC | 4 | $607 |
| Novartis | 20 | $339 |
| Amgen | 18 | $315 |
| ZOLL Services LLC (a/k/a ZOLL Lifecor Corp) | 21 | $261 |
| Medtronic(2 entities) | 8 | $187 |
| Johnson & Johnson | 11 | $166 |
| Biotronik Inc. | 9 | $136 |
| Amarin Pharma, Inc. | 7 | $114 |
| Boston Scientific | 4 | $103 |
| Inari Medical, Inc. | 1 | $86 |
| W. L. Gore & Associates, Inc. | 3 | $80 |
| AstraZeneca | 5 | $72 |
| Pfizer | 2 | $41 |
| Bardy Diagnostics, Inc. | 1 | $40 |
| Veryan Medical Incorporated | 1 | $38 |
| Terumo Medical Corporation | 1 | $32 |
| Regeneron Healthcare Solutions, Inc. | 2 | $30 |
| Novo Nordisk | 1 | $20 |
| Cardinal Health 200 LLC | 1 | $18 |
| Boehringer Ingelheim | 1 | $16 |
| Intact Vascular, Inc. | 1 | $15 |
| United Therapeutics Corporation | 1 | $15 |
| Lexicon Pharmaceuticals, Inc. | 1 | $13 |
| E.r. Squibb & Sons, L.L.C. | 1 | $12 |
| Reflow Medical Inc | 1 | $5 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- Allure CRT Pacemaker$957
- AFX$467
- Supera peripheral stent system$170
- ESPRIT$111
How this compares
$5,620 in reported general payments places this provider in the 75th percentile of 827 cardiovascular disease providers in Ohio.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Other cardiovascular disease in Mount Vernon
- Som BaileyMount Vernon$56K
- Guilherme AttizzaniCleveland$1.3M
- Gregory LamCircleville$428K
- Emil HayekHudson$379K
- Abraham LincoffCleveland$369K
- Oussama WazniCleveland$367K
- Ian NeelandCleveland$329K
- Kamal ShemisaCincinnati$314K
- Mehdi ShishehborElyria$237K
- Abdu HawwaGarfield Hts$234K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.